Aspira Pathlab

86.27
+4.10
(4.99%)
Market Cap
88.82 Cr
EPS
-2.60
PE Ratio
100.21
Dividend Yield
0.00 %
52 Week High
83.93
52 Week low
25.00
PB Ratio
4.38
Debt to Equity
0.16
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,530.35 21,149.24 50.76 2,295.80 11.52 362 19.34 45.50
1,006.95 10,334.27 73.53 568.60 20.11 120 35.77 50.92
1,612.65 8,267.63 54.57 1,216.80 4.59 129 15.38 38.56
669.25 3,546.48 41.81 581.30 8.63 70 29.25 38.13
723.20 2,335.20 30.16 636.40 25.65 57 49.23 37.03
1,756.95 1,507.95 31.47 86.70 25.47 32 58.82 45.49
243.78 775.48 7.33 1,436.10 35.04 6 -1,081.25 42.21
277.95 197.39 17.55 63.00 248.07 7 133.33 48.26
128.50 89.49 70.71 36.90 6.34 1 0.00 54.20
86.27 88.82 100.21 13.60 -8.11 -3 142.86 70.11
Growth Rate
Revenue Growth
-8.11 %
Net Income Growth
2,600.00 %
Cash Flow Change
10,600.00 %
ROE
3,662.86 %
ROCE
-976.44 %
EBITDA Margin (Avg.)
-143.40 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
3
4
5
6
6
Expenses
3
4
4
5
5
EBITDA
-0
-0
0
1
1
Operating Profit %
-17 %
-5 %
6 %
21 %
11 %
Depreciation
0
0
0
0
0
Interest
0
0
0
0
0
Profit Before Tax
-1
-1
0
1
0
Tax
0
0
0
0
0
Net Profit
-1
-1
0
1
0
EPS in ₹
-0.70
-0.49
0.05
0.96
0.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
4
6
15
13
15
14
12
18
17
15
Fixed Assets
0
0
8
8
9
9
8
10
8
7
Current Assets
4
6
4
2
2
3
4
7
6
4
Capital Work in Progress
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
Other Assets
4
6
7
5
6
6
4
9
9
8
Total Liabilities
4
6
15
13
15
14
12
18
17
15
Current Liabilities
0
3
6
2
4
5
2
2
2
2
Non Current Liabilities
0
0
3
11
5
5
2
4
3
3
Total Equity
4
4
6
0
5
4
8
13
13
10
Reserve & Surplus
1
1
1
-5
-8
-10
-7
-2
-3
-5
Share Capital
2
2
5
5
8
9
10
10
10
10

Cash Flow

Cash Flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
-3
1
-2
-0
3
0
-1
0
Investing Activities
0
-10
-1
-2
0
-0
-1
0
0
Operating Activities
-0
-1
-5
-3
-2
6
2
0
1
Financing Activities
3
9
7
3
1
-2
-1
-1
-1

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
36.25 %
36.25 %
36.25 %
36.25 %
36.25 %
36.25 %
36.19 %
34.55 %
19.48 %
19.47 %
19.37 %
19.37 %
18.90 %
18.90 %
18.72 %
18.72 %
18.55 %
18.55 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.41 %
40.41 %
40.41 %
40.33 %
40.33 %
41.47 %
43.33 %
40.92 %
52.60 %
51.49 %
51.76 %
51.76 %
52.24 %
51.99 %
55.71 %
59.15 %
61.26 %
60.28 %
Others
23.34 %
23.34 %
23.34 %
23.42 %
23.42 %
22.28 %
20.48 %
24.54 %
27.91 %
29.04 %
28.87 %
28.87 %
28.86 %
29.11 %
25.57 %
22.13 %
20.19 %
21.18 %
No of Share Holders
536
535
535
710
852
868
955
1,141
1,300
1,300
1,371
1,371
1,406
1,351
1,512
1,695
1,706
1,593

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 08, 2025, 14:31
Integrated Filing (Financial)
Feb 07, 2025, 18:10
Board Meeting Outcome for For Unaudited Financial Results (Both Standalone & Consolidated) Alongwith Limited Review Report For The Quarter And Nine Months Ended December 31 2024 And Other Businesses T
Feb 07, 2025, 17:31
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Jan 31, 2025, 13:33
Reconstitution Of Audit And Stakeholder Relationship Committee W.E.F February 01 2025
Jan 29, 2025, 13:47
Announcement under Regulation 30 (LODR)-Resignation of Director
Jan 22, 2025, 19:15
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 08, 2025, 14:08
Intimation For Change In The Name Of The Registrar And Share Transfer Agent
Jan 02, 2025, 13:36
Closure of Trading Window
Dec 27, 2024, 12:37
Inauguration Of New Diagnostics Centre At Andheri, Mumbai
Dec 02, 2024, 13:39
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 13, 2024, 22:05
Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Along With Limited Review Report For Quarter/Half Year Ended September, 2024
Nov 12, 2024, 18:51
Board Meeting Intimation for To Consider And Approve Unaudited Standalone And Consolidated Financial Results For The Quarter/Half Year Ended September 2024 And Transact Other Businesses
Oct 29, 2024, 16:26
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 07, 2024, 16:35
Closure of Trading Window
Sep 30, 2024, 12:56
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Sep 27, 2024, 22:37
Re-Appointment Of Dr. Haseeb Drabu (DIN:00489888) As Non Executive And Independent Director Of The Company For The Second Term Of 5 Years
Sep 27, 2024, 22:27
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 27, 2024, 22:10
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 27, 2024, 18:42
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 06, 2024, 21:30
Notice Convening 51St Annual General Meeting For The Financial Year 2023-24
Sep 05, 2024, 23:38
Reg. 34 (1) Annual Report.
Sep 05, 2024, 22:47
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 04, 2024, 14:02
Book Closure & E-Voting Intimation For The Purpose 51St Annual General Meeting
Aug 24, 2024, 11:50
51St Annual General Meeting Of The Company To Be Held On Friday, September 27, 2024 At 12.00 P.M (IST)
Aug 24, 2024, 11:39
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Aug 19, 2024, 21:26
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 14, 2024, 18:14
Announcement Under Regulation 30-Re-Appointment Of Dr. Haseeb Drabu (DIN: 00489888), Non-Executive & Independent Director Of The Company For The Period Of 5 Years
Aug 13, 2024, 18:51
Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30 ,2024
Aug 13, 2024, 18:26
Board Meeting Intimation for Considering Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30, 2024 & Other Business Matters As On August 13, 2024.
Aug 03, 2024, 18:36
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 07, 2024, 19:08
Closure of Trading Window
Jun 29, 2024, 19:38
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Jun 29, 2024, 18:37
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Jun 29, 2024, 18:28
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Jun 29, 2024, 18:21
Reminder To Update KYC Details Pursuant To SEBI Circulars
Jun 08, 2024, 14:16
Announcement under Regulation 30 (LODR)-Newspaper Publication
May 30, 2024, 17:25
Compliances-Reg.24(A)-Annual Secretarial Compliance
May 29, 2024, 14:56
Intimation For The Appointment Of Secretarial Auditor And Internal Auditor Of The Company
May 28, 2024, 18:34
Board Meeting Outcome for For The Quarter And The Financial Year Ended March 31, 2024
May 28, 2024, 18:20
Board Meeting Intimation for To Consider And Approve Audited Financial Statements Of The Company As On March 31, 2024 And To Discuss Any Other Matter With The Permission Of The Chair.
May 18, 2024, 14:44
Compliance Certificate As Per Regulation 7(3) Of The SEBI(LODR)Regulations, 2015 For The Financial Year Ended March 31, 2024.
Apr 17, 2024, 14:06
Compliance Certificate Under Regulation 40(9 & 10) Of The SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2024
Apr 10, 2024, 19:25
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Apr 09, 2024, 11:40
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Apr 09, 2024, 10:54
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Apr 04, 2024, 18:20
Intimation Under Regulation 30 Of The SEBI(LODR)Regulations, 2015-Incorporation Of Limited Liability Partnership.
Apr 04, 2024, 17:48
Intimation Under Regulation 30 Of SEBI(LODR)Regulation, 2015-Incorporation Of Limited Liability Partnership.
Apr 02, 2024, 21:26
Inauguration Of A Two New Diagnostics Centers Today In Nashik And Malad.
Apr 01, 2024, 11:18
Closure of Trading Window
Mar 29, 2024, 10:41

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
69.03
ATR(14)
Less Volatile
2.85
STOCH(9,6)
Overbought
95.93
STOCH RSI(14)
Overbought
99.18
MACD(12,26)
Bullish
1.66
ADX(14)
Strong Trend
31.90
UO(9)
Bearish
83.23
ROC(12)
Uptrend And Accelerating
29.73
WillR(14)
Overbought
-2.24